177Lu-Labeled Anticlaudin 6 Monoclonal Antibody for Targeted Therapy in Esophageal Cancer

© 2025 by the Society of Nuclear Medicine and Molecular Imaging. Immediate Open Access: Creative Commons Attribution 4.0 International License (CC BY) allows users to share and adapt with attribution, excluding materials credited to previous publications. License: https://creativecommons.org/licenses/by/4.0/. Details: https://jnm.snmjournals.org/page/permissions.

Author Information

Huan Du*,¹,
Xiaofei Hao*,¹,
Binwei Lin*,¹,²,
Mingming Tang³,
Decai Wang¹,²,³,⁴,
Xia Yang⁵,
Jing Wang⁵,
Liling Qin⁶,
Yuchuan Yang⁵ and
Xiaobo Du¹,²,³,⁴

¹Mianyang Central Hospital, School of Medicine, University of Electronic Science and Technology of China, Mianyang, China;
²NHC Key Laboratory of Nuclear Technology Medical Transformation, Mianyang Central Hospital, School of Medicine, University of Electronic Science and Technology of China, Mianyang, China;
³Clinical Medical School, North Sichuan Medical College, Nanchong, China;
⁴Sichuan Clinical Research Center for Radiation and Therapy, Mianyang Central Hospital, Mianyang, China;
⁵Institute of Nuclear Physics and Chemistry, China Academy of Engineering Physics, Mianyang, China; and
⁶Pathology Department, First People’s Hospital of Mianyang, Mianyang, China